Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan

Código QR

Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan

Yu-Shian Cheng,1,2 Yu-Chiau Shyu,3,4 Sheng-Yu Lee,5,6 Shin-Sheng Yuan,7 Chun-Ju Yang,8 Kang-Chung Yang,8,9 Tung-Liang Lee,10 Liang-Jen Wang1 1Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 2Department of Psychiatr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cheng YS, Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Wang LJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	ADHD adult epidemiology pharmacotherapy comorbidity non-Caucasian Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f106fa17e47946868d5cc0157ce38277
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nationwide Rate of Adult ADHD Diagnosis and Pharmacotherapy from 2015 to 2018
por: Sang-Min Lee, et al.
Publicado: (2021)

Prevalence and Clinical Characteristics of the Restless Legs Syndrome (RLS) in Patients Diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) in Antioquia
por: Ana Carolina Sierra Montoya, et al.
Publicado: (2018)

Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
por: Feng-Hua Loh, et al.
Publicado: (2021)

SPECT Functional Neuroimaging Distinguishes Adult Attention Deficit Hyperactivity Disorder From Healthy Controls in Big Data Imaging Cohorts
por: Daniel G. Amen, et al.
Publicado: (2021)

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
por: Lee H, et al.
Publicado: (2020)

Method of quality improvement and economic efficiency of pharmacotherapy for community-acquired pneumonia and its utility in Ukraine health-care facilities
por: A.B. Zimenkovsky
Publicado: (2020)

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
por: Chan MH, et al.
Publicado: (2017)

High Risk for Attention-Deficit Hyperactive Disorder in Children with Strabismus: A Nationwide Cohort Study from the National Health Insurance Research Database
por: Chia-Ying Tsai, et al.
Publicado: (2021)

Prediction of Suicidality According to Serum Folate Levels in Depressive Patients Receiving Stepwise Pharmacotherapy
por: Jae-Min Kim, et al.
Publicado: (2021)

Falls in nursing home residents receiving pharmacotherapy for anemia
por: Reardon G, et al.
Publicado: (2012)

Comparison of Persistence and Adherence Between Adults Diagnosed with Attention Deficit/Hyperactivity Disorder in Childhood and Adulthood
por: Lee SM, et al.
Publicado: (2021)

Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?
por: Wang LJ, et al.
Publicado: (2017)

EFFICIENCY OF PHARMACOTHERAPY IN ALLERGIC RHINITIS, AS EVALUATED BY DECREASED CONCENTRATIONS OF FREE HEMOGLOBIN IN NASAL SECRETIONS
por: A. A. Mokronosova, et al.
Publicado: (2014)

Pharmacotherapy Update and Review for Family Medicine Residents Using Jeopardy-Style Game
por: Giselle Ellis
Publicado: (2020)

The pharmacotherapy of acute viral hepatitis B: a clinical pharmacist's view
por: O.Yu. Horodnycha, et al.
Publicado: (2020)

Multiple Arterial Variations in the Right Upper Limb of a Caucasian Male Cadaver
por: Al-fayez,Musaed A, et al.
Publicado: (2010)

Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study
por: Witczak I, et al.
Publicado: (2020)

Optimal management of ADHD in older adults
por: Torgersen T, et al.
Publicado: (2016)

Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
por: Hertanto DM, et al.
Publicado: (2021)

RETROSPECTIVE STUDY: INITIAL PHARMACOTHERAPY PROFILE OF NEW ACNE VULGARIS PATIENTS
por: Esravila Ariya Wibisono, et al.
Publicado: (2020)

THE CORRELATION OF PARENTING STYLE WITH COGNITIVE DEVELOPMENT IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
por: Fitri Genisti, et al.
Publicado: (2018)

Pharmacology, Pharmacotherapy, and Pharmacopolicy Through an Evidence-Based Medicine: A Novel Approach for First-Year Medical Students
por: Alexander M. Mozeika, et al.
Publicado: (2020)

Cognitive Behavioral Therapy and Pharmacotherapy for the Treatment of Tobacco Use Disorder in Primary Care for Resident Physicians
por: Juhee C. McDougal, et al.
Publicado: (2019)

Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders
por: Lamanna AL, et al.
Publicado: (2017)

PREVALENCE OF AUTISM SPECTRUM DISORDERS (ASD) AND ATTENTION DEFICIT HYPERACTIVITY DISORDERS (ADHD) AMONG ADULT PSYCH
por: Sana Khan, et al.
Publicado: (2019)

Autistic Traits and Empathy in Children With Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder and Co-occurring Attention Deficit Hyperactivity Disorder/Autism Spectrum Disorder
por: Stefania Aiello, et al.
Publicado: (2021)

Programa de trastornos de personalidad de la Clínica Psiquiátrica Universitaria: un enfoque multidisciplinario
por: Jerez,Sonia, et al.
Publicado: (2001)

Measures of executive functions predicting Attention-Deficit/Hyperactivity Disorder core symptoms
por: Tshikani T. Boshomane, et al.
Publicado: (2021)

The association between polygenic scores for attention‐deficit/hyperactivity disorder and school performance: The role of attention‐deficit/hyperactivity disorder symptoms, polygenic scores for educational attainment, and shared familial factors
por: Andreas Jangmo, et al.
Publicado: (2021)

Unique Trans-fatty Acid Profile in Children With Attention Deficit Hyperactivity Disorder
por: Ayelet Armon-Omer, et al.
Publicado: (2021)

Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service
por: Noh GM, et al.
Publicado: (2018)

Attention–memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder
por: Farias AC, et al.
Publicado: (2017)

Association Between Attention Deficit Hyperactivity Disorder and Risk of Burn Injury: A Propensity-Matched Cohort Study
por: Yeh JY, et al.
Publicado: (2020)

Comparison of Medical Comorbidity between Patients with Normal-Tension Glaucoma and Primary Open-Angle Glaucoma: A Population-Based Study in Taiwan
por: Wei-Yang Lu, et al.
Publicado: (2021)

Reference values for anterior chamber morphometrics with swept-source optical coherence tomography in a Caucasian population
por: Römkens HC, et al.
Publicado: (2018)

The Implementation of CBT to Reduce Hyperactive Behaviors among Adolescents with ADHD
por: Khofidotur Rofiah, et al.
Publicado: (2021)

Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou WJ, et al.
Publicado: (2018)

Comparison of Indexes to Measure Comorbidity Burden and Predict All-Cause Mortality in Rheumatoid Arthritis
por: Yun-Ju Huang, et al.
Publicado: (2021)

Psychometric Properties of a Brief Screening Measure for ADHD in Adults
por: Blessing Bakare, et al.
Publicado: (2020)

Assessment and monitoring of treatment response in adult ADHD patients: current perspectives
por: Ramsay JR
Publicado: (2017)